 "Metropolis Healthcare's Rs 1,200-cr IPO to open for subscription on Apr 3")
Diagnostics company Metropolis Healthcare’s Rs 1,200-crore initial public offer (IPO) will open for subscription on April 3 and close on April 5.
The offering comprises of secondary sale of 13.68 million shares, constituting of 27.3 per cent stake.
The price band for the IPO is Rs 877 to Rs 880 per share. At the top-end the IPO will mobilise Rs 1,200 crore and value the company at Rs 4,416 crore.
Those selling in the IPO are promoter Sushil Shah and private equity Lotus Investments.
JM Financial, Credit Suisse, Goldman Sach, HDFC Bank and Kotak Mahindra Capital are the investment banks handling the IPO.
Metropolis offers range of clinical laboratory tests used for prediction, detection and monitoring of the disease.
Metropolis also offers analytical and support services to clinical research organisations.
For the nine-month period ended December 2018, the company had clocked net profit of Rs 89 crore on revenues of Rs 560 crore.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%